Lloyds Banking Share Discussion Threads

[diku] 08/4/2020 10:06

Yes because they make more money out of loan/interest payments...and less haggling of the price as the buyer is gullible with smaller monthly payments..unlike a cash buyer might just over haggle the price down...a boom last few years...



maxk
8 Apr '20 - 09:41 - 299877 of 299880
0   1  0



I get the distinct feeling car dealers dont want cash buyers.

They prefer you to buy via a loan, from which they get a rake off.

[poikka] 08/4/2020 09:58

Hmm, might be coming up for the time to change my 7 year-old Skoda. It's an ill wind...

[mr.elbee] 08/4/2020 09:58

so have the French and the Indians,mitchy

hydroxychloroquine.

Never ever get it here.

It offends the holy NHS

[ladeside] 08/4/2020 09:50

maxk, Yes, they're only pushing PCP, it's even quite difficult to get a deal on HP nowadays as they obviously aren't making as much commission off those loans.

[1carus] 08/4/2020 09:43

Ingeresting t0 see what comes out of America today. Trumpy was starting to blame everyone else but himself yesterday, employment numbers are going to be bad. US death toll is gonna be huge... luckily there are areas in the US that do have very low population densities for the area of land that they have, but from what I can see, other than a closure of restaurants, life goes on as normal for many areas... people think the lockdown measures are just optional over there.

[maxk] 08/4/2020 09:41

I get the distinct feeling car dealers dont want cash buyers.

They prefer you to buy via a loan, from which they get a rake off.

[ladeside] 08/4/2020 09:41

God sake man, my 28.5 could be in danger here !!!

[cheshire pete] 08/4/2020 09:34

Agree CTR: Pay cash every 2 years. Get a good deal plus it is a good way of ensuring taking some profit out of the market. You see a lot of flash cars around but sense a lot of them on finance.

[crossing_the_rubicon] 08/4/2020 09:29

@Diku,

Agreed. I have little sympathy for those that are over stretched on their car leases.
Especially the Audi and Range Rover crowd.

[aljm] 08/4/2020 09:16

probably leasing them or drug dealers IMO

[diku] 08/4/2020 09:14

When you see lots of newer BMWs, Mercs, Audis and SUVs on the road driven by the normal joe public one wonders what do they do for a living...it makes them look important...






Crossing_the_Rubicon
8 Apr '20 - 08:44 - 299862 of 299870
0   0  0



Fears are growing of a crisis in the UK’s £75bn car loan market, where 6.5m vehicles have been financed through leasing deals with monthly payments that are already proving unaffordable for some laid-off as a result of the coronavirus. The Finance and Leasing Association (FLA), which represents the credit arms of the car manufacturers as well as the banks, said: “It’s early days in terms of quantifying the impact on arrears, but the number of forbearance requests has grown significantly in recent weeks.” – Guardian

"Oh dear next bubble set to burst"

[cheshire pete] 08/4/2020 08:57

buywell3, re: #846, and your point about the 10 month average duration of bear markets, whilst it is true that history can repeat itself I need a bit more convincing that this COVID-19 induced bear market is typical.
It has not resulted from the usual causes such as markets over valued, wars, 9/11, sub-prime, loss of confidence, oil price hikes, interest rate rises etc. Yes COVID-19 will become COVID-20 and 21, but vaccines will be developed and the news from Melbourne re: the existing FDA approved parasitic drug gives hope that solutions might happen sooner rather than later.
With Governments, Central Banks round the world prepared to stimulate economies I think that this bear market could be short lived and in time seen as a short term correction. Yes Goldman Sachs and Morgan Stanley are talking things down but frankly I don't trust them.

[crossing_the_rubicon] 08/4/2020 08:51

More debt defaults coming PC..
9th default by Argies.
Why we continue lending to people who regularly default beggars belief.

[patientcapital] 08/4/2020 08:51

Argentina $10bn debt default the other day may not be an isolated case.

[crossing_the_rubicon] 08/4/2020 08:47

As an aside, just because someone works for a Pharmaceutical company doesnt mean they know anything about the pathology of viruses etc.

After all, plenty of people who work in Finance havent a clue about Finance. As ample evidence before us in the current markets evidences.

Attempting to solve a debt crisis by taking on even more debt!

And look where we are.

In even bigger trouble than 2007/2008

[aljm] 08/4/2020 08:46

well, it did come from the guardian, i think that paper is just about one step up from the Beano,

[maxidi] 08/4/2020 08:46

CTR...
Brilliant answer to Ace. LMAO :o)

[crossing_the_rubicon] 08/4/2020 08:44

Fears are growing of a crisis in the UK’s £75bn car loan market, where 6.5m vehicles have been financed through leasing deals with monthly payments that are already proving unaffordable for some laid-off as a result of the coronavirus. The Finance and Leasing Association (FLA), which represents the credit arms of the car manufacturers as well as the banks, said: “It’s early days in terms of quantifying the impact on arrears, but the number of forbearance requests has grown significantly in recent weeks.” – Guardian

"Oh dear next bubble set to burst"

[cheshire pete] 08/4/2020 08:06

Good find stonedyou.

[stonedyou] 08/4/2020 07:54

Cure found for COVID-19 with a single dose of an already FDA approved drug?
University of Melbourne and Royal Melbourne Hospital pushes for human trial and funding


Juergen T SteinmetzApril 8, 2020 04:19


A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with

the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint

venture of the University of Melbourne and Royal Melbourne Hospital, has shown

that an anti-parasitic drug already available around the world kills the virus

within 48 hours.


Although several clinical trials are now underway to test possible therapies, the

worldwide response to the COVID-19 outbreak has been largely limited to

monitoring/containment. Ivermectin, an FDA-approved anti-parasitic previously

shown to have broad-19 spectrum anti-viral activity in vitro, is an inhibitor of

the causative virus.

The use of Ivermectin to combat COVID-19 depends on pre-clinical testing and

clinical trials, with funding urgently required to progress the work.

In Australia, a Monash University-led collaborative study was published in

Antiviral Research, a peer-reviewed medical journal



The Monash Biomedicine Discovery Institute’s Dr Kylie Wagstaff, who led the study,

said the scientists showed that the drug, Ivermectin, stopped the SARS-CoV-2 virus

growing in cell culture within 48 hours.

“We found that even a single dose could essentially remove all viral RNA by 48

hours and that even at 24 hours there was a really significant reduction in it,”

Dr Wagstaff said.

Ivermectin is an FDA-approved anti-parasitic drug that has also been shown to be

effective in vitro against a broad range of viruses including HIV, Dengue,

Influenza and Zika virus.

Dr Wagstaff cautioned that the tests conducted in the study were in vitro and that

trials needed to be carried out in people.
________________________________________

“Ivermectin is very widely used and seen as a safe drug. We need to figure out now

whether the dosage you can use it in humans will be effective – that’s the next

step,” Dr Wagstaff said.

“In times when we’re having a global pandemic and there isn’t an approved

treatment, if we had a compound that was already available around the world then

that might help people sooner. Realistically it’s going to be a while before a

vaccine is broadly available.

Although the mechanism by which Ivermectin works on the virus is not known, it is

likely, based on its action in other viruses, that it works to stop the

virus ‘dampening down’ the host cells’ ability to clear it, Dr Wagstaff said.

Royal Melbourne Hospital’s Dr Leon Caly, a Senior Medical Scientist at the

Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty

Institute where the experiments with live coronavirus were conducted, is the

study’s first author.

“As the virologist who was part of the team who were first to isolate and share

SARS-COV2 outside of China in January 2020, I am excited about the prospect of

Ivermectin being used as a potential drug against COVID-19,” Dr Caly said.

[stonedyou] 08/4/2020 07:53

Cure found for COVID-19 with a single dose of an already FDA approved drug?
University of Melbourne and Royal Melbourne Hospital pushes for human trial and funding


Juergen T SteinmetzApril 8, 2020 04:19


A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with

the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint

venture of the University of Melbourne and Royal Melbourne Hospital, has shown

that an anti-parasitic drug already available around the world kills the virus

within 48 hours.


Although several clinical trials are now underway to test possible therapies, the

worldwide response to the COVID-19 outbreak has been largely limited to

monitoring/containment. Ivermectin, an FDA-approved anti-parasitic previously

shown to have broad-19 spectrum anti-viral activity in vitro, is an inhibitor of

the causative virus.

The use of Ivermectin to combat COVID-19 depends on pre-clinical testing and

clinical trials, with funding urgently required to progress the work.

In Australia, a Monash University-led collaborative study was published in

Antiviral Research, a peer-reviewed medical journal



The Monash Biomedicine Discovery Institute’s Dr Kylie Wagstaff, who led the study,

said the scientists showed that the drug, Ivermectin, stopped the SARS-CoV-2 virus

growing in cell culture within 48 hours.

“We found that even a single dose could essentially remove all viral RNA by 48

hours and that even at 24 hours there was a really significant reduction in it,”

Dr Wagstaff said.

Ivermectin is an FDA-approved anti-parasitic drug that has also been shown to be

effective in vitro against a broad range of viruses including HIV, Dengue,

Influenza and Zika virus.

Dr Wagstaff cautioned that the tests conducted in the study were in vitro and that

trials needed to be carried out in people.
________________________________________

“Ivermectin is very widely used and seen as a safe drug. We need to figure out now

whether the dosage you can use it in humans will be effective – that’s the next

step,” Dr Wagstaff said.

“In times when we’re having a global pandemic and there isn’t an approved

treatment, if we had a compound that was already available around the world then

that might help people sooner. Realistically it’s going to be a while before a

vaccine is broadly available.

Although the mechanism by which Ivermectin works on the virus is not known, it is

likely, based on its action in other viruses, that it works to stop the

virus ‘dampening down’ the host cells’ ability to clear it, Dr Wagstaff said.

Royal Melbourne Hospital’s Dr Leon Caly, a Senior Medical Scientist at the

Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty

Institute where the experiments with live coronavirus were conducted, is the

study’s first author.

“As the virologist who was part of the team who were first to isolate and share

SARS-COV2 outside of China in January 2020, I am excited about the prospect of

Ivermectin being used as a potential drug against COVID-19,” Dr Caly said.